Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Immatics Biotechnologies (Germany) | Researchclopedia

Back to institutions

Immatics Biotechnologies (Germany)

Tübingen, Baden-Wurttembergcompany

221

Works

55,380

Citations

100

h-index

Top Research Topics

Immunotherapy and Immune Responses CAR-T cell therapy research Cancer Immunotherapy and Biomarkers

Top Researchers

1,101 works36,952 citationsh-index: 106

Recent Research

Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model

Felicia S. Spitzer,Marcel Camps,et al.

20250 citations

vaccines and immunoinformatics approaches

Monoclonal and Polyclonal Antibodies Research

Immune Cell Function and Interaction

T-cell and B-cell Immunology

Biosimilars and Bioanalytical Methods

Peptidase Inhibition and Analysis

Cancer Research and Treatments

Immune Response and Inflammation

Immune cells in cancer

Anna K. Nowak Wrocław University of Science and Technology

647 works29,950 citationsh-index: 87

Stefan Stevanović TH Bingen University of Applied Sciences

515 works28,717 citationsh-index: 85

Jörn Dengjel University of Fribourg

322 works26,974 citationsh-index: 65

Michael Staehler München Klinik

485 works22,420 citationsh-index: 65

Peter Brossart University Hospital Bonn

551 works19,867 citationsh-index: 75

77MO A phase I trial of IMA203CD8, a PRAME-directed TCR T cell therapy in PRAME-positive solid tumors

A. Busse,D.M. Araujo,et al.

20250 citations

590 A first-in-human, phase 1 trial of IMA203 PRAME-directed TCR T-cell therapy with PRAME-encoding mRNA-4203 in previously treated, unresectable or metastatic cutaneous melanoma or synovial sarcoma

James W. Smithy,Rodabe Navroze Amaria,et al.

20250 citations

579 Quality of starting material result in high manufacturability and favorable product phenotype of IMA203, a PRAME-directed TCR T-cell therapy

M. Alper Kursunel,Brent C. Chesson,et al.

20250 citations

TMOD-18. Tumor Ablation and Immune Microenvironment Modulation Following Laser Interstitial Thermal Therapy in a Murine Glioblastoma Model

Ashley Puentes,Prazwal Athukuri,et al.

20250 citations

603 SUPRAME: a phase 3 trial evaluating IMA203 PRAME-directed TCR T-cell therapy vs investigator’s choice in previously treated advanced cutaneous melanoma

Justin Moser,Rodabe N Amaria,et al.

20250 citations